Results 71 to 80 of about 694 (96)

The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations. [PDF]

Future Oncol
George S, Blay JY, Chi P, Jones RL, Serrano C, Somaiah N, Gelderblom H, Zalcberg JR, Reichmann W, Sprott K, Cox P, Sherman ML, Ruiz-Soto R, Heinrich MC, Bauer S.   +14 more
europepmc   +1 more source

Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease. [PDF]

Hematol Oncol Clin North Am
Cicala CM, Bauer S, Heinrich MC, Serrano C.   +3 more
europepmc   +1 more source

Modern times call for modernized treatment strategies for advanced gastrointestinal stromal tumors. [PDF]

J Gastrointest Oncol
Perati SR, Blakely AM.
europepmc   +1 more source

Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review. [PDF]

Cancers (Basel)
Houmsse M, Muskara A, Pasca D, Roy A, Sughra S, Ghazi S, Addison D, Husain M.   +7 more
europepmc   +1 more source

Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR. [PDF]

Acta Pharmacol Sin
Cai JF, Zhou JS, Meng ZY, Wu ZQ, Zhao JC, Peng HX, Liang XY, Chen JJ, Wang PP, Deng K.   +9 more
europepmc   +1 more source

What determines value? Exploring value characteristics of novel therapies for digestive system cancers. [PDF]

Front Immunol
Ou S, Wang S, Chen X, Li H, Zhou C, Jiang Q.   +5 more
europepmc   +1 more source

Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis. [PDF]

World J Clin Oncol
Li J, Zhang H, Chen XD.
europepmc   +1 more source

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study. [PDF]

Cancers (Basel)
Lim SY, Ferro-López L, Barquin E, Lindsay D, Thway K, Smith MJ, Benson C, Jones RL, Napolitano A.   +8 more
europepmc   +1 more source

Peritoneal Sarcomatosis Secondary to a Gastrointestinal Stromal Tumor Treated With a Multimodal Approach: A Case Report. [PDF]

Cureus
Perez Zambrano AD, Garcia Mora M, Rios Acuña S.   +2 more
europepmc   +1 more source

KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape. [PDF]

J Clin Oncol
Mühlenberg T, Falkenhorst J, Schulz T, Fletcher BS, Teuber A, Krzeciesa D, Klooster I, Lundberg M, Wilson L, Lategahn J, von Mehren M, Grunewald S, Tüns AI, Wardelmann E, Sicklick JK, Brahmi M, Serrano C, Schildhaus HU, Sievers S, Treckmann J, Heinrich MC, Raut CP, Ou WB, Marino-Enriquez A, George S, Rauh D, Fletcher JA, Bauer S.   +27 more
europepmc   +1 more source